Found 6 matching trials
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
PHASE3The purpose of this study is to demonstrate the superiority of MD1003 over ...
Location
Barrow Neurology Clinics (BNC)
Effect of MD1003 in Spinal Progressive Multiple Sclerosis
PHASE3The purpose of this study is to demonstrate the superiority of MD1003 over ...
Location
Hopital Pellegrin
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
PHASE2The single-center, open-label Phase II study has the objective of assess th...
Location
Hôpital Henri Mondor, Créteil, France
MD1003-AMN MD1003 in Adrenomyeloneuropathy
PHASE2The primary objective of the trial is to demonstrate the superiority of bio...
Effect of MD1003 in Amyotrophic Lateral Sclerosis
PHASE2This is a 6-month double blind randomized 2:1 placebo-controlled study with...
Location
Hopital Gui De Chauliac
Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis
PHASE3The purpose of this study is to demonstrate the superiority of MD1003 over ...
Location
Hopital Pellegrin